Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Viral Infection and Antiviral Treatments in Ocular Pathologies.Microorganisms · 2022
   Review
2. Cold atmospheric plasma as antiviral therapy - effect on human herpes simplex virus type 1.The Journal of general virology · 2020
   Article
3. Severe presentation of antibody-negative, postinfectious steroid-responsive encephalitis and atonic bladder after herpes simplex encephalitis.BMJ case reports · 2019
   Article
4. Public health trends in neurologically relevant infections: a global perspective.Therapeutic advances in infectious disease
   Review

Corrections and comments

• Commented on by
  Response to the letter to the editor by Andreas Sauerbrei on "Acyclovir resistance in herpes simplex type I encephalitis, a case report".2017
• Comment on
  Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as